BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress

Journal of Cell Science

Volumn 122, Issue 1, 2009, Pages 36-43

  Baj, Gabriele ^a   Tongiorgi, Enrico ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Brain derived neurotrophic factor; Drug resistance; Neuroblastoma; Serum deprivation; SH SY 5Y; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MESSENGER RNA; RETINOIC ACID; SMALL INTERFERING RNA; ISOPROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXON; GENE SILENCING; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; TRANSCRIPTION REGULATION; UPREGULATION; ALTERNATIVE RNA SPLICING; ANIMAL; CELL LINE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS;

ALTERNATIVE SPLICING; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; EXONS; HUMANS; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RECEPTOR, TRKB; STRESS, PHYSIOLOGICAL; TRETINOIN;

EID: 62149115739     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.033316     Document Type: Article

References (44)

1. Alarcon, C. M., Pedram, M. and Donelson, J. E. (1999). Leaky transcription of variant surface glycoprotein gene expression sites in bloodstream african trypanosomes. J. Biol. Chem. 274, 16884-16893.
2. Aoyama, M., Asai, K., Shishikura, T., Kawamoto, T., Miyachi, T., Yokoi, T., Togari, H., Wada, Y., Kato, T. and Nakagawara, A. (2001). Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett. 164, 51-60.
3. Bibel, M. and Barde, Y. A. (2000). Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14, 2919-2937.
4. Boon, K., Caron, H. N., van Asperen, R., Valentijn, L., Hermus, M. C., van Sluis, P., Roobeek, I., Weis, I., Voute, P. A., Schwab, M. et al. (2001). N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20, 1383-1393.
5. Brodeur, G. M. (1995). Molecular basis for heterogeneity in human neuroblastomas. Eur. J. Cancer 31A, 505-510.
6. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. and Bishop, J. M. (1984). Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124.
7. Brodeur, G. M., Azar, C., Brother, M., Hiemstra, J., Kaufman, B., Marshall, H., Moley, J., Nakagawara, A., Saylors, R., Scavarda, N. et al. (1992). Neuroblastoma: effect of genetic factors on prognosis and treatment. Cancer 70, 1685-1694.
8. Casaccia-Bonnefil, P., Gu, C. and Chao, M. V. (1999). Neurotrophins in cell survival/death decisions. Adv. Exp. Med. Biol. 468, 275-282.
9. Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R. and Greenberg, M. E. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889.
10. Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Cena, V., Gallego, C. and Comella, J. X. (2000). Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75, 991-1003.
11. Feng, X., Jiang, H., Baik, J. C., Edgar, C. and Eide, F. F. (2001). BDNF dependence in neuroblastoma. J. Neurosci. Res. 64, 355-363.
12. Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K. and Gewirtz, D. A. (1994). Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol. Pharmacol. 45, 649-656.
13. Garzon, D. J. and Fahnestock, M. (2007). Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J. Neurosci. 27, 2628-2635.
14. Goodman, L. A., Liu, B. C., Thiele, C. J., Schmidt, M. L., Cohn, S. L., Yamashiro, J. M., Pai, D. S., Ikegaki, N. and Wada, R. K. (1997). Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin. Exp. Metastasis 15, 130-139.
15. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699.
16. Hande, K. R. (1998). Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34, 1514-1521.
17. Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E. and Brodeur, G. M. (2002). Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res. 62, 6462-6466.
18. Huang, E. J. and Reichardt, L. F. (2003). Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642.
19. Jaboin, J., Kim, C. J., Kaplan, D. R. and Thiele, C. J. (2002). Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res. 62, 6756-6763.
20. Jaboin, J., Hong, A., Kim, C. J. and Thiele, C. J. (2003). Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma. Cancer Lett. 193, 109-114.
21. Jordan, M. A. and Wilson, L. (2004). Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265.
22. Klein, D., Kern, R. M. and Sokol, R. Z. (1995). A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem. Mol. Biol. Int. 36, 59-66.
23. Lauterborn, J. C., Rivera, S., Stinis, C. T., Hayes, V. Y., Isackson, P. J. and Gall, C. M. (1996). Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J. Neurosci. 16, 7428-7436.
24. Liu, Q. R., Walther, D., Drgon, T., Polesskaya, O., Lesnick, T. G., Strain, K. J., de Andrade, M., Bower, J. H., Maraganore, D. M. and Uhl, G. R. (2005). Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134, 93-103.
25. Marmigere, F., Choby, C., Rage, F., Richard, S. and Tapia-Arancibia, L. (2001). Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures. Neuroendocrinology 74, 43-54.
26. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G. and Sun, Y. E. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893.
27. Matthay, K. K. (1995). Neuroblastoma: a clinical challenge and biologic puzzle. CA Cancer J. Clin. 45, 179-192.
28. Metsis, M., Timmusk, T., Arenas, E. and Persson, H. (1993). Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc. Natl. Acad. Sci. USA 90, 8802-8806.
29. Middlemas, D. S., Kihl, B. K., Zhou, J. and Zhu, X. (1999). Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J. Biol. Chem. 274, 16451-16460.
30. Nakagawara, A. and Brodeur, G. M. (1997). Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur. J. Cancer 33, 2050-2053.
31. Nakagawara, A., Azar, C. G., Scavarda, N. J. and Brodeur, G. M. (1994). Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol. 14, 759-767.
32. Nanda, S. and Mack, K. J. (1998). Multiple promoters direct stimulus and temporal specific expression of brain-derived neurotrophic factor in the somatosensory cortex. Brain Res. Mol. Brain Res. 62, 216-219.
33. Olesen, K. M. and Auger, A. P. (2005). Sex differences in fos protein expression in the neonatal rat brain. J. Neuroendocrinol. 17, 255-261.
34. Pruunsild, P., Kazantseva, A., Aid, T., Palm, K. and Timmusk, T. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90, 397-406.
35. Sano, K., Nanba, H., Tabuchi, A., Tsuchiya, T. and Tsuda, M. (1996). BDNF gene can Be activated by Ca2+ signals without involvement of de novo AP-1 synthesis. Biochem. Biophys. Res. Commun. 229, 788-793.
36. Schwab, M. (2004). MYCN in neuronal tumours. Cancer Lett. 204, 179-187.
37. Schweigerer, L., Breit, S., Wenzel, A., Tsunamoto, K., Ludwig, R. and Schwab, M. (1990). Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. Cancer Res. 15, 4411-4416.
38. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y. and Hammond, D. (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111-1116.
39. Tao, X., West, A. E., Chen, W. G., Corfas, G. and Greenberg, M. E. (2002). A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 33, 383-395.
40. Timmusk, T., Persson, H. and Metsis, M. (1994). Analysis of transcriptional initiation and translatability of brain-derived neurotrophic factor mRNAs in the rat brain. Neurosci. Lett. 177, 27-31.
41. Wakamatsu, Y., Watanabe, Y., Nakamura, H. and Kondoh, H. (1997). Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development 124, 1953-1962.
42. Wang, M. J., Liu, S., Liu, Y. and Zheng, D. (2007). Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells. Neurosci. Res. 59, 40-46.
43. West, A. E., Griffith, E. C. and Greenberg, M. E. (2002). Regulation of transcription factors by neuronal activity. Nat. Rev. Neurosci. 3, 921-931.
44. Yamashiro, D. J., Liu, X. G., Lee, C. P., Nakagawara, A., Ikegaki, N., McGregor, L. M., Baylin, S. B. and Brodeur, G. M. (1997). Expression and function of Trk-C in favourable human neuroblastomas. Eur. J. Cancer 33, 2054-2057.